cifenline has been researched along with Body Weight in 2 studies
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cibenzoline dosing is generally based on renal function, but serum concentrations might be greater than the expected therapeutic levels when standard oral dosing is used." | 1.33 | Heart failure elevates serum levels of cibenzoline in arrhythmic patients. ( Kamakura, S; Kitakaze, M; Komamura, K; Kotake, T; Miyatake, K; Morishita, H; Takada, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotake, T | 1 |
| Takada, M | 1 |
| Komamura, K | 1 |
| Kamakura, S | 1 |
| Miyatake, K | 1 |
| Kitakaze, M | 1 |
| Morishita, H | 1 |
| Herpin, D | 1 |
| Gaudeau, B | 1 |
| Amiel, A | 1 |
| Bauple, JL | 1 |
| Boutaud, P | 1 |
| Demange, J | 1 |
2 other studies available for cifenline and Body Weight
| Article | Year |
|---|---|
Heart failure elevates serum levels of cibenzoline in arrhythmic patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Body Weight; Drug Evaluation; Female; Heart | 2006 |
[Activity and tolerance of a new anti-arrhythmia drug, Cibenzoline (Cipralan), administered orally)].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Body Weight; Cardiac Complexes, Premature | 1981 |